-
HEPA Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Hepion Pharmaceuticals (HEPA)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.50 mm | 1.50 mm | 1.50 mm | 1.50 mm | 1.50 mm | 1.50 mm |
Cash burn (monthly) | 3.87 mm | 2.42 mm | 1.62 mm | 2.74 mm | 33.33 k | 2.00 mm |
Cash used (since last report) | 10.90 mm | 6.82 mm | 4.57 mm | 7.71 mm | 93.93 k | 5.63 mm |
Cash remaining | -9.41 mm | -5.32 mm | -3.07 mm | -6.21 mm | 1.40 mm | -4.13 mm |
Runway (months of cash) | -2.4 | -2.2 | -1.9 | -2.3 | 42.1 | -2.1 |
13F holders | Current |
---|---|
Total holders | 26 |
Opened positions | 7 |
Closed positions | 2 |
Increased positions | 4 |
Reduced positions | 4 |
13F shares | Current |
---|---|
Total value | 1.78 bn |
Total shares | 2.30 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Hirschman Orin | 1.17 mm | $2.52 mm |
CVI Investments | 420.00 k | $920.00 k |
Armistice Capital | 390.00 k | $971.10 mm |
Vanguard | 157.36 k | $391.83 mm |
BLK BlackRock | 82.95 k | $206.56 mm |
Geode Capital Management | 38.83 k | $96.72 mm |
STT State Street | 15.68 k | $39.03 mm |
Susquehanna International | 14.64 k | $36.44 mm |
PNC The PNC Financial Services Group, Inc. | 7.88 k | $19.62 mm |
Tower Research Capital | 1.90 k | $4.73 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Mar 24 | Purcell Michael J. | RSU Common Stock | Grant | Acquire A | No | No | 0 | 50,000 | 0.00 | 50,000 |
19 Feb 24 | Kaouthar Lbiati | Stock Options Common Stock | Grant | Acquire A | No | No | 2.56 | 85,000 | 217.60 k | 88,000 |
19 Feb 24 | Block Timothy M. | Stock Options Common Stock | Grant | Acquire A | No | No | 2.56 | 85,000 | 217.60 k | 99,562 |
19 Feb 24 | Brancaccio John P | Stock Options Common Stock | Grant | Acquire A | No | No | 2.56 | 85,000 | 217.60 k | 99,563 |